LLY Congressional Stock Trades
Eli Lilly and Company Common Stock (LLY)
Last disclosed trade Jun 2
Every disclosed trade in LLY by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Coldpine’s read
Greene's purchase coincides with three other congressional members buying LLY within a 30-day window, indicating cluster interest in the pharma giant. The 5-day disclosure lag is notably prompt, keeping the trade actionable for observers. The position size aligns with her typical small-to-mid range disclosures rather than signaling an outsized conviction bet.
Marjorie Taylor Greene · Bought · May 14
Coldpine scores and writes a rationale for every congressional trade. See the full scored analysis with Pro →
Follow $LLY
Get notified when any member of Congress trades $LLY. Free, no card, no spam.
Members who trade LLY
Recent disclosed trades in LLY
| Date | Member | Type | Amount |
|---|---|---|---|
| Jun 2 | Rohit Khanna(CA) | buy | $1K–$15K |
| Apr 13 | Rohit Khanna(CA) | sell | $1K–$15K |
| Apr 9 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Apr 8 | Elizabeth Fletcher(TX) | sell | $1K–$15K |
| Apr 2 | Byron Donalds(FL) | buy | $1K–$15K |
| Apr 2 | Byron Donalds(FL) | buy | $1K–$15K |
| Feb 26 | David J. Taylor(OH) | buy | $1K–$15K |
| Feb 13 | Angus S King(ME) | sell | $1K–$15K |
| Feb 9 | David J. Taylor(OH) | sell | $1K–$15K |
| Jan 16 | David J. Taylor(OH) | sell | $1K–$15K |
| Dec 29 | Markwayne Mullin(OK) | buy | $15K–$50K |
| Dec 29 | Angus S King(ME) | buy | $1K–$15K |
| Dec 16 | Thomas H. Kean(NJ) | exch | $1K–$15K |
| Dec 16 | Thomas H. Kean(NJ) | exch | $1K–$15K |
| Dec 16 | August Lee Pfluger(TX) | exch | $1K–$15K |
| Dec 10 | David J. Taylor(OH) | sell | $1K–$15K |
| Dec 9 | Michael T. McCaul(TX) | buy | $15K–$50K |
| Nov 7 | Rohit Khanna(CA) | exch | $15K–$50K |
| Oct 27 | Michael T. McCaul(TX) | sell | $15K–$50K |
| Oct 22 | Rohit Khanna(CA) | buy | $1K–$15K |
Showing 20 of 72 disclosed trades.
Sign up free for the full history, signal scores, and price-vs-trades chart. Pro adds Coldpine's read — the AI narrative on each trade.
Create a free accountData sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores — free with an account →